| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/09/2014 | WO2014007190A1 Cell-spreading device and method for detecting rare cell |
| 01/09/2014 | WO2014007034A1 Analysis device and analysis method |
| 01/09/2014 | WO2014006952A1 Method for detecting indicator of exacerbation of chronic obstructive pulmonary disease |
| 01/09/2014 | WO2014006638A1 Device and method for blood hemoglobin measurement without carboxyhemoglobin interference |
| 01/09/2014 | WO2014006561A2 Method and devices for detecting macroions in a liquid medium |
| 01/09/2014 | WO2014006408A1 Lipocalin-2 as a biomarker for pneumococcal infection status and uses thereof |
| 01/09/2014 | WO2014006406A1 Sensor calibration method and apparatus |
| 01/09/2014 | WO2014006397A2 Pore analysis |
| 01/09/2014 | WO2014006394A2 An electrode and use thereof |
| 01/09/2014 | WO2014006244A1 Method and device for the rapid diagnosis of diseases caused by yersinia, in faecal samples |
| 01/09/2014 | WO2014006234A1 Integrated system for the early detection of hydrocarbons in an aqueous medium |
| 01/09/2014 | WO2014006227A1 Simultaneous detection of cannibalism and senescence as prognostic marker for cancer |
| 01/09/2014 | WO2014006225A1 Fluorescent fusion polypeptide, biosensor comprising said polypeptide and uses thereof |
| 01/09/2014 | WO2014006224A1 Tropomyosin isoforms related to alzheimers disease and mild cognitive impairment |
| 01/09/2014 | WO2014006208A1 System and use thereof for determining an in-situ pollutant reduction potential of soils at contaminated sites and method for determining an in- situ pollutant reduction potential while avoiding contamination of adjacent layers of soil |
| 01/09/2014 | WO2014006163A1 Hmga2 as a marker for diagnosing diabetes |
| 01/09/2014 | WO2014006129A1 Determination of a conversion factor relating the conductivity and the hardness of water |
| 01/09/2014 | WO2014006128A1 Method and apparatus for determining the temporary hardness of water |
| 01/09/2014 | WO2014006079A1 Method for diagnosing psychiatric disorders in a human subject assessing the concentration of sp1, sp3 and sp4 proteins in a biological sample |
| 01/09/2014 | WO2014006043A2 Selection device |
| 01/09/2014 | WO2014005931A1 System for measuring physicochemical parameters of the transfer of a gas through a porous solid material |
| 01/09/2014 | WO2014005909A1 In vitro method for the diagnosis and surveillance of cancer |
| 01/09/2014 | WO2014005869A1 Arrangement for quantifying cells of a cell suspension |
| 01/09/2014 | WO2014005527A1 Method for improving sensitivity of competitive immunoassay |
| 01/09/2014 | WO2014005299A1 Quantum dot-protein complexes, films, and methods of use |
| 01/09/2014 | WO2014005298A1 Enzyme-linked immunosorbent assay kit for detecting dinitolmide and use thereof |
| 01/09/2014 | WO2013173499A3 Diagnostic methods and devices for monitoring chronic glycemia |
| 01/09/2014 | WO2013171446A3 Device for saliva testing |
| 01/09/2014 | WO2013167727A3 Method for determining arthritis relapse risk |
| 01/09/2014 | WO2013166338A3 Cell capture system and use thereof |
| 01/09/2014 | WO2013151756A8 Electrodes for sensing chemical composition |
| 01/09/2014 | WO2013150375A3 Endothelial cells activation biomarkers characterizing antibody mediated rejection and uses thereof |
| 01/09/2014 | WO2013150127A3 Polymers containing multivalent amyloid-beta-binding d-peptides and their use |
| 01/09/2014 | WO2013148267A3 Epigenetics in autoimmunity |
| 01/09/2014 | WO2013144344A3 Biomarkers for hpv infections, related diagnostic methods and kits |
| 01/09/2014 | WO2013142153A3 Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics |
| 01/09/2014 | WO2013124740A3 BRCA DEFICIENCY PROTEIN AND mRNA SIGNATURES USEFUL IN IDENTIFICATION OF PATIENTS WITH BRCA-DEFICIENT TUMORS AND PREDICTING BENEFIT OF ANTI-CANCER THERAPY IN CANCER PATIENTS |
| 01/09/2014 | WO2013106772A3 Characterization of subvisible particles using a particle analyzer |
| 01/09/2014 | WO2012135944A9 Protein kinase inhibitors |
| 01/09/2014 | US20140012602 System for managing treatment of a particular health condition |
| 01/09/2014 | US20140012540 Apparatus and method for automatically monitoring an apparatus for processing meat products |
| 01/09/2014 | US20140012530 Arrangement and Method for Calibrating at Least Two Sensors in Parallel |
| 01/09/2014 | US20140012527 Diagnostic method for determining whether machine element is reusable |
| 01/09/2014 | US20140012504 Quantitative assessment of soil contaminants, particularly hydrocarbons, using reflectance spectroscopy |
| 01/09/2014 | US20140011895 Biomarkers for systemic lupus erythematosus |
| 01/09/2014 | US20140011890 Methods and compositions for treating neuropathies |
| 01/09/2014 | US20140011879 Serum markers for identification of cutaneous systemic sclerosis subjects |
| 01/09/2014 | US20140011866 Akt phosphorylation at ser473 as an indicator for taxane-based chemotherapy |
| 01/09/2014 | US20140011831 Use of opioid antagonists |
| 01/09/2014 | US20140011821 Egfr mutations |
| 01/09/2014 | US20140011815 Fitness assay and associated methods |
| 01/09/2014 | US20140011811 Myosin binding protein-c for use in methods relating to diastolic heart failure |
| 01/09/2014 | US20140011761 Modulating Endoplasmic Reticulum Stress in the Treatment of Tuberous Sclerosis |
| 01/09/2014 | US20140011748 Methods Of Predicting Response To JNK Inhibitor Therapy |
| 01/09/2014 | US20140011737 Compositions and methods for regulating metabolism |
| 01/09/2014 | US20140011709 Screening assays and methods |
| 01/09/2014 | US20140011705 Detection of protease and protease activity using a single nanocrescent sers probe |
| 01/09/2014 | US20140011700 Three-dimensional structure of h1n1 nucleoprotein in complex with antiviral compounds |
| 01/09/2014 | US20140011698 Simultaneous detection of biomolecules in single cells |
| 01/09/2014 | US20140011696 Bap1 mutational analysis in determining susceptibility to, prognosis of, and treatment of melanocytic neoplasia |
| 01/09/2014 | US20140011695 Markers for identifying breast cancer treatment modalities |
| 01/09/2014 | US20140011692 Methods for the survey and genetic analysis of populations |
| 01/09/2014 | US20140011691 Morphology and protein specific reagents as diagnostics for neurodegenerative diseases |
| 01/09/2014 | US20140011689 Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids |
| 01/09/2014 | US20140011687 Methods for the survey and genetic analysis of populations |
| 01/09/2014 | US20140011294 Immunoassay Product and Process |
| 01/09/2014 | US20140011285 Detection of hydrocarbons in aqueous environments |
| 01/09/2014 | US20140011274 Isolation and use of solid tumor stem cells |
| 01/09/2014 | US20140011255 Biotin Derivatives |
| 01/09/2014 | US20140011230 Method for Identifying and Screening Dendritic Killer Cells |
| 01/09/2014 | US20140011220 Devices And Methods For Detecting Amniotic Fluid In Vaginal Secretions |
| 01/09/2014 | US20140011219 Grafted dinuclear metal complexes, and use thereof as cellular microparticle sensors |
| 01/09/2014 | US20140011218 Rapid peptidoglycan-based assay for detection of bacterial contamination |
| 01/09/2014 | US20140011216 Engineered pertactin variants for vaccine use |
| 01/09/2014 | US20140011215 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 01/09/2014 | US20140011213 Membrane bound reporter molecules and their use in cell sorting |
| 01/09/2014 | US20140011212 Trifunctional crosslinking reagents |
| 01/09/2014 | US20140011211 Method of diagnosing the presence and/or severity of a hepatic pathology in an individual and/or of monitoring the effectiveness of a treatment for one such pathology |
| 01/09/2014 | US20140011210 Actinobacillus suis antigens |
| 01/09/2014 | US20140011209 Aptamers for Prion Diagnostics and Aptamer Binding Detection System |
| 01/09/2014 | US20140011208 Xanthene dyes comprising a sulfonamide group |
| 01/09/2014 | US20140011207 Psa binding aptamer and method for diagnosis of prostate cancer |
| 01/09/2014 | US20140011205 Leukocyte activation and methods of use thereof |
| 01/09/2014 | US20140011197 Alzheimer's Disease Cellular Model for Diagnostic and Therapeutic Development |
| 01/09/2014 | US20140011193 Aptamer-based lateral flow assay and associated methods |
| 01/09/2014 | US20140010825 Diagnostic and therapeutic potential of HLA-E monospecific monoclonal IgG antibodies directed against tumor cell surface and soluble HLA-E |
| 01/09/2014 | US20140010824 Methods, compositions and kits for treating or preventing a disease associated with Gram-negative bacteria |
| 01/09/2014 | US20140010817 Novel Antibodies and Uses Thereof |
| 01/09/2014 | US20140010777 Methods for determining personalized treatment compositions for prostate cancer and breast cancer |
| 01/09/2014 | US20140010763 Activatable fluorogenic compounds and uses thereof as near infrared probes |
| 01/09/2014 | US20140010762 Imaging agents |
| 01/09/2014 | US20140010758 Peptidomimetic inhibitors of psma |
| 01/09/2014 | US20140010757 Imaging methods using engineered integrin binding peptides |
| 01/09/2014 | US20140010712 Apparatus for detecting a selected liquid contaminant |
| 01/09/2014 | US20140009170 Pavement Material Microwave Moisture-Density Measurement Methods and Apparatuses |
| 01/09/2014 | US20140008281 Device, method, and system for separation and detection of biomolecules and cells |
| 01/09/2014 | US20140008245 Determination of blood glucose in a small volume and in a short test time using a chemical coating inluding binders and very short read potentials |
| 01/09/2014 | US20140008218 Biosensor, biosensor chip and biosensor device |
| 01/09/2014 | US20140008217 Biosensor, biosensor chip and biosensor device |
| 01/09/2014 | US20140008216 Biosensor, biosensor chip and biosensor device |